SIRT5 and breast carcinoma: Polletta et al. demonstrated that ammonia production decreased in SIRT5 overexpressing MDA-MB-231 breast cancer cells, which was corroborated by the increase in ammonia production in SIRT5-silenced cells or cells treated with a specific inhibitor of SIRT5 (MC3482) [75].